Histone deacetylase 6 (HDAC6) is a therapeutic target in non-central nervous system (CNS) cancers that is receiving increasing scrutiny in GBM [1,2,3,4,5,6,7,8,9]. The gene discussed is HDAC6; the disease is cancer.